GLPwatch
Trials (2036)
Page 29 of 34.
- Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
- The Effect of Semaglutide on Pituitary Function
- Phase 2a Placebo-Controlled Study of VTX3232 Alone or in Combination With Semaglutide in Obesity
- Incretin and Treatment With Inhibition of Sodium-glucose Cotransporter-2 Combination Insights Into Mechanisms Implicated in Congestive Heart Failure: "NATRIURETIC" Trial
- Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study
- Quality of Life and Fixed-ratio Combination of Insulin Degludec and Liraglutide (iDegLira)
- JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With Obesity
- The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET
- The Effect of Lixisenatide on the Effect of Pituitary Hormones
- Glucagon-like Peptide (GLP) Utilization and Safety
- Tirzepatide Titration to Reduce Side Effects in Individuals With Obesity
- Efficacy of Semaglutide in Glycemic Control, Weight Loss, and Improving Lipidogram- Role of Baseline Vitamin D Levels
- Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion Therapies
- Examination of the Effects of Liraglutide on the Mode of Action of Insulin Detemir
- A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet
- A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Chinese Men
- Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients
- BetaFIT Study: Beta Cell Imaging After Faecal mIcrobiota Transplantation
- SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without Diabetes
- The Effect of Exenatide on Fasting Bile Acids
- A Drug Interaction Study of Cyclosporine and LY3502970 in Healthy Participants
- 68Ga-NODAGA-exendin-4 PET/CT for Diagnostic Imaging in AHH
- Feasibility Study of Exenatide by Continuous Subcutaneous Infusion
- Treatment of Bile Acid Malabsorption With Liraglutide
- SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies
- A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes Patients
- Liraglutide Effectiveness in Preoperative Weight-loss for Bariatric-metabolic Surgery
- Effect of Gelofusine on GLP1-receptor Imaging
- A Study to Test Whether BI 456906 (Survodutide) Influences the Amount of Bupropion, Caffeine and Midazolam in the Blood in People With Overweight or Obesity
- Clinical Trial for PB-119 in Healthy Subjects (Phase I)
- Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.
- A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term
- Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide
- A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
- A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
- A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity
- A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants
- Prediction of the SEPRA Diabetes Trial in Healthcare Claims Data
- A Study of Cardiovascular Events iN Diabetes Plus
- To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study
- Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes
- A Study Comparing the Efficacy and Safety of HRS9531 Injection With Semaglutide Injection in Subjects With Obesity
- Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis
- Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients
- A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice
- This is a Study to Evaluate the Pharmacokinetics and Safety of IBI362 in Chinese Adolescents With Obesity
- A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes
- Influence of Liraglutide, a GLP-1 Receptor Agonist, on Brown Adipose Tissue (BAT) Activity in Humans
- A Study of Tirzepatide (LY3298176) in Participants With Obesity Disease
- A GLP-1 Receptor PET Imaging Substudy Within the VER-A-T1D Trial Investigating the Effects on Beta Cell Mass
- Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin
- Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function
- Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables
- A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver
- A Research Study Looking at Similarity Between LY3437943 Versions for Different Injection Devices
- Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)
- Autoinjector Device Assessment Study
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practice